November 25th 2023
From late-life treatment-resistant depression to the mental health benefits of gratitude, here are highlights from the week in Psychiatric Times.
November 21st 2023
In this CME, review the risks and clinical implications of intimate partner violence on women’s substance use and treatment.
November 14th 2023
Young men appear to be particularly susceptible to the effects of cannabis on schizophrenia.
November 3rd 2023
What is new in research on SUDs?
October 23rd 2023
“Epidemiological surveys have shown that gender gaps and alcohol consumption and alcohol-related harms are narrowing for women and men—such that alcohol is growing women’s health issue.”
Getting Started With Buprenorphine
An expert addresses some common concerns about the drug and some effective ways clinicians can initiate the treatment at the 2023 Annual Psychiatric Times™ World CME Conference.
Schizophrenia Research Roundup: October 20
What is new in research on schizophrenia?
Cannabis, Psychosis, and the Legal Implications: Chicken or Egg?
Explore the relationship between cannabis use and psychosis.
The Week in Review: September 18-22
From violence risk assessment in emergency departments to connections between bipolar disorder and substance use disorders, here are highlights from the week in Psychiatric Times.
How Do Treatments for Bipolar Disorder and SUD Affect One Another?
An expert discusses the connections between the 2 highly comorbid diseases and some ways to effectively treat both diseases simultaneously.
Special Populations Research Roundup: September 15
What is new in research on psychiatric care for Latinx patient populations?
Cannabis Use Disorder and Schizophrenia in Males Versus Females
What is the association between cannabis use disorders and schizophrenia? Researchers used a nationwide register-based cohort study to investigate these associations.
Acknowledging International Overdose Awareness Day
Today is International Overdose Awareness Day!
NIDA Awards Grant of Up to $16.6M for Research on Investigational OUD Treatment
The funds will be distributed over the course of 5 years to support preclinical through phase 2 studies.
The Week in Review: August 21-25
From informed consent in treatment with psychedelics to an anti-fentanyl antibody that may reverse the signs of carfentanil overdose, here are highlights from the week in Psychiatric Times.
Study Shows That Anti-Fentanyl Antibody Reverses Signs of Carfentanil Overdose
“We expect this antibody to be a valuable new weapon for fighting the opioid crisis.”
From the Pages of Psychiatric Times: July 2023
The experts weighed in on a wide variety of psychiatric issues for the July 2023 issue of Psychiatric Times.
The Week in Review: July 17-21
From a look at adolescent substance use to special challenges in treating borderline personality disorder during the perinatal period, here are highlights from the week in Psychiatric Times.
Adolescent Substance Use: Reasons for Optimism and Concern
"Although adolescent substance use is a topic that can be challenging for families and clinicians alike, data demonstrate that interventions during this time are effective for preventing, identifying, and reducing risky use."
The Week in Review: June 26-30
From an examination of the fentanyl epidemic to the connection between ADHD medication and height, here are highlights from the week in Psychiatric Times.
Fentanyl: Accelerant of the Adolescent Opioid Crisis
How can we turn the tide of the fentanyl epidemic?
Continued Cannabis Confusion
Should cannabis be regulated in the United States in a manner similar to alcohol and tobacco?
The Week in Review: June 5-9
From adherence in addiction recovery treatment to the relationship between social media use and youth mental health, here are highlights from the week in Psychiatric Times.
Adherence in Addiction Recovery Treatment: Surrender is Scary, Yet Critical
Here’s how you can effectively encourage treatment adherence when helping patients with substance use disorder.
The Week in Review: May 29-June 2
From substance use among adolescents and young adults to managing behavioral and psychological symptoms of dementia, here are highlights from the week in Psychiatric Times.
Substance Use Among Adolescents and Young Adults
In this CME, check out best practices for screening and treating adolescents and young adults with substance use issues.
Investigating the Impact of ADHD on Smoking Cessation Outcomes
What is the connection?
Looking Toward the Future of American Psychiatry
Petros Levounis, MD, MA, reflects on his upcoming presidency for the American Psychiatric Association.
Exploring the Future of Mental Health
A look at the theme for the 2023 American Psychiatric Association Annual Meeting.
Teach and Treat Your Children Well
"It is essential to have an aggressive path forward to increase public awareness of mental health and illness, education on early intervention and treatment access, and continued destigmatization of mental illness."
Everything You Need to Know When Referring Patients to Ketamine Therapy Clinics
Ketamine is relatively new to the average American. What can you share with them as a mental health clinician?
The Week in Review: May 1-5
From new FDA treatment approvals to choosing the right levels of care in crisis stabilization units, here are highlights from the week in Psychiatric Times.
An Imperfect Guide to Crisis Stabilization Units: Matching the Right Level of Care to Individual Needs
Here’s how having a clear understanding of the services different crisis stabilization units provide can help communities serve the unique needs of each individual in crisis without unnecessarily restrictive or intensive levels of care.
From the Pages of Psychiatric Times: April 2023
The experts weighed in on a wide variety of psychiatric issues for the April 2023 issue of Psychiatric Times.
The Week in Review: April 10-14
From to co-occurring substance use and eating disorders to treatment options for OCD, here are highlights from the week in Psychiatric Times.
2 Clarke Drive Cranbury, NJ 08512